Fig. 2From: Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancerProliferation and migration of PN and inhibition by anti-PN peptide. a-b Proliferation effect by the PN-transfected experiment compared with mock transfected BCA cells without or with anti-PN peptide, c-d Proliferation effect study by rPN and/or anti-PN peptide treatment, e-f Migration study by wound healing assay compared between PN and mock transfected BCA cells and inhibition by anti-PN peptide and (g-h) Migration study by wound healing assay compared between by rPN treatment BCA cells and inhibition by anti-PN peptide. M = mock transfected, PN = PN-transfected, error bar determined standard error of mean (SEM), * = P-value < 0.05, ** = P-value < 0.001 and n.s. = not significantBack to article page